Search details
1.
Impact of Increasing PD-L1 Levels on Outcomes to PD-1/PD-L1 Inhibition in Patients With NSCLC: A Pooled Analysis of 11 Prospective Clinical Trials.
Oncologist
; 29(5): 422-430, 2024 May 03.
Article
in English
| MEDLINE | ID: mdl-38349736
2.
SAM: Self-adapting mixture prior to dynamically borrow information from historical data in clinical trials.
Biometrics
; 79(4): 2857-2868, 2023 12.
Article
in English
| MEDLINE | ID: mdl-37721513
3.
FDA Approval Summary: Revised Indication and Dosing Regimen for Ponatinib Based on the Results of the OPTIC Trial.
Oncologist
; 27(2): 149-157, 2022 03 04.
Article
in English
| MEDLINE | ID: mdl-35641211
4.
FDA Approval Summary: Ruxolitinib for Treatment of Chronic Graft-Versus-Host Disease after Failure of One or Two Lines of Systemic Therapy.
Oncologist
; 27(6): 493-500, 2022 06 08.
Article
in English
| MEDLINE | ID: mdl-35363318
5.
FDA Approval Summary: Atezolizumab and Durvalumab in Combination with Platinum-Based Chemotherapy in Extensive Stage Small Cell Lung Cancer.
Oncologist
; 26(5): 433-438, 2021 05.
Article
in English
| MEDLINE | ID: mdl-33687763
6.
US Food and Drug Administration review of statistical analysis of patient-reported outcomes in lung cancer clinical trials approved between January, 2008, and December, 2017.
Lancet Oncol
; 20(10): e582-e589, 2019 10.
Article
in English
| MEDLINE | ID: mdl-31579004
7.
FDA Supplemental Approval: Blinatumomab for Treatment of Relapsed and Refractory Precursor B-Cell Acute Lymphoblastic Leukemia.
Oncologist
; 23(11): 1366-1371, 2018 11.
Article
in English
| MEDLINE | ID: mdl-30018129
8.
FDA Approval Summary: Ivosidenib in Combination with Azacitidine for Treatment of Patients with Newly Diagnosed Acute Myeloid Leukemia with an IDH1 Mutation.
Clin Cancer Res
; 30(7): 1226-1231, 2024 Apr 01.
Article
in English
| MEDLINE | ID: mdl-38010220
9.
FDA Approval Summary: Decitabine and Cedazuridine Tablets for Myelodysplastic Syndromes.
Clin Cancer Res
; 28(16): 3411-3416, 2022 08 15.
Article
in English
| MEDLINE | ID: mdl-35435961
10.
FDA Approval Summary: Oral Azacitidine for Continued Treatment of Adults with Acute Myeloid Leukemia Unable to Complete Intensive Curative Therapy.
Clin Cancer Res
; 28(14): 2989-2993, 2022 07 15.
Article
in English
| MEDLINE | ID: mdl-35325108
11.
Improving Dose-Optimization Processes Used in Oncology Drug Development to Minimize Toxicity and Maximize Benefit to Patients.
J Clin Oncol
; 40(30): 3489-3500, 2022 10 20.
Article
in English
| MEDLINE | ID: mdl-36095296
12.
Response Rate, Event-Free Survival, and Overall Survival in Newly Diagnosed Acute Myeloid Leukemia: US Food and Drug Administration Trial-Level and Patient-Level Analyses.
J Clin Oncol
; 40(8): 847-854, 2022 03 10.
Article
in English
| MEDLINE | ID: mdl-34890212
13.
FDA Approval Summary: Belumosudil for Adult and Pediatric Patients 12 Years and Older with Chronic GvHD after Two or More Prior Lines of Systemic Therapy.
Clin Cancer Res
; 28(12): 2488-2492, 2022 06 13.
Article
in English
| MEDLINE | ID: mdl-35135839
14.
Overview of Oncology and Hematology Drug Approvals at US Food and Drug Administration Between 2008 and 2016.
J Natl Cancer Inst
; 111(5): 449-458, 2019 05 01.
Article
in English
| MEDLINE | ID: mdl-30085269
Results
1 -
14
de 14
1
Next >
>>